US Edition
Natalizumab better than anti CD20?
Summary by Multiple Sclerosis Research Blog
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Natalizumab better than anti CD20?
Tweet Last week we had a post from Norway saying anti-CD20 was better than cladribine, today a post form the Middle East saying natalizumab was better than anti-CD20 Yamout B, Alroughani R, Mohamed SFA, Al-Mahdawi AM, Khoury SJ, El Ayoubi N, Inshasi J, Alkhaboori J, Al-Asmi A, Gouider R, Aljarallah S, Alkhawajah N, Al Malik Y, Abulaban A, Makkawi S, Khojah O, El-Hajj T, Massouh J, AlSalamat H, Dimassi H, Al-Hajje A, Salameh P, Boumediene F, Zein…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
